RRM2 and gastric cancer: Knocking down of RRM2 significantly perturbed cell growth rate and meanwhile sensitized gastric cancer cells to chemotherapy, suggesting the possibility of insufficient suppression of RRM2 by using HZ-A-018 and the existence of alternative molecular targets of HZ-A-018 in gastric cancer cells.